Luly Jay R. Insider Trades

Insider Trading History

Track insider trading activity for Luly Jay R.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $12.3M 871,871 shares
Last Trade
Feb 12, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$87.7k 6,155 shares
$14.25
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $12.3M 878,026 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$277k 20,000 shares
$13.84
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $12.1M 858,026 shares
Last Trade
Dec 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.5k 4,743 shares
$14.23
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $12.1M 862,769 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.6k 1,885 shares
$14.12
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $4.36M 310,000 shares
Last Trade
Nov 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.23M 310,000 shares
$13.66
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.9M 846,638 shares
Last Trade
Feb 12, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$256k 45,000 shares
$5.69
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $12.3M 872,138 shares
Last Trade
Feb 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$149k 25,500 shares
$5.86
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $12.2M 864,654 shares
Last Trade
Feb 12, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$41.8k 7,484 shares
$5.59
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.3M 801,638 shares
Last Trade
Dec 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$41.4k 5,142 shares
$8.06
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.3M 806,780 shares
Last Trade
Dec 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$32.9k 3,829 shares
$8.60
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $3.52M 250,000 shares
Last Trade
Nov 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.21M 250,000 shares
$8.83
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.4M 810,609 shares
Last Trade
Feb 12, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.7k 1,584 shares
$12.41
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.4M 812,193 shares
Last Trade
Feb 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.6k 5,400 shares
$12.33
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.3M 806,793 shares
Last Trade
Dec 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$69.6k 7,230 shares
$9.63
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.4M 814,023 shares
Last Trade
Dec 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$54.9k 5,787 shares
$9.49
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $3.71M 264,000 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 264,000 shares
$8.99
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $0 0 shares
Last Trade
Mar 13, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.26M 27,912 shares
$45.07
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.8M 837,025 shares
Last Trade
Mar 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.26M 27,912 shares
$45.16
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.9M 847,722 shares
Last Trade
Mar 13, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.26M 27,912 shares
$45.07
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
President And CEO
Holding Value $11.5M 819,810 shares
Last Trade
Feb 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.09M 20,591 shares
$52.77
$14.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up